CDI Blood parameter monitoring system 500 H/SAT, Part No. 145883 Product Usage: The CDI Syste...
FDA Device Recall #Z-2750-2018 — Class II — June 26, 2018
Recall Summary
| Recall Number | Z-2750-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 26, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Terumo Cardiovascular Systems Corporation |
| Location | Ann Arbor, MI |
| Product Type | Devices |
| Quantity | 128 in total |
Product Description
CDI Blood parameter monitoring system 500 H/SAT, Part No. 145883 Product Usage: The CDI System 500 provides continuous, on-line monitoring of the extracorporeal partial pressure of oxygen and carbon dioxide, pH, potassium, oxygen saturation, hematocrit, hemoglobin and temperature. In addition, calculated values of base excess, bicarbonate, oxygen saturation, and oxygen consumption may also be provided. These parameters are displayed at either actual temperature or adjusted to 37¿C. For documentation purposes, the system 500s integral printer provides a hard copy of displayed parameters.
Reason for Recall
H/Sat Hybrid Intensity Shift has been seen in a subset of the H/Sat population, which has resulted in an increase of Hybrids failing the H/Sat Color Chip Test which is an automated self-test when the device is powered on. This will not result in device inaccuracy, only Color Chip Test Failure which disables the H/Sat module.
Distribution Pattern
Worldwide Distribution - US Nationwide in the states of AL, AZ, CA, FL, GA, IL, KY, LA, MA, MD, MI, MN, MO, MS, NC, NM, NY, OH, SC, TN, TX, WA, and WV. Foreign distribution to Middle East, Latin America, Europe, Japan, Canada, and Mexico.
Lot / Code Information
H011684 H011685 H011686 H011687 H011688 H011689 H011691 H011692 H011693 H011694 H011695 H011696 H011697 H011699 H011700 H011701 H011702 H011704 H011705 H011706 H011707 H011708 H011709 H011710 H011711 H011712 H011713 H011714 H011715 H011717 H011718 H011719 H011721 H011722 H011723 H011725 H011726 H011727 H011730 H011731 H011732 H011733 H011735 H011736 H011737 H011738 H011742 H011744 H011745 H011747 H011749 H011750 H011751 H011752 H011753 H011754 H011755 H011756 H011757 H011758 H011759 H011760 H011761 H011762 H011766 H011772 H011778 H011779 H011780 H011781 H011783 H011784 H011785 H011786 H011788 H011789 H011790 H011791 H011792 H011793 H011794 H011795 H011796 H011797 H011798 H011799 H011800 H011801 H011803 H011804 H011805 H011806 H011807 H011808 H011809 H011810 H011811 H011812 H011813 H011814 H011815 H011817 H011819 H011821 H024598 H024599 H024600 H024601 H024602 H024603 H024604 H024605 H024606 H024607 H024608 H024611 H024612 H024613 H024614 H024615 H024616 H024617 H024618 H024620 H024621 H024624 H024625 H024626 H024627 H024628 H024629 H024631 H024632 H024633 H024635 H024636 H024637 H024638 H024639 H024641 H024642 H024643 H024645 H024647 H024649 H024652 H024654 H024655 H024657 H024659 H024674
Other Recalls from Terumo Cardiovascular Systems Corpora...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2018-2025 | Class II | CDI OneView System BPM Probe: Cat. No. CDI75... | May 28, 2025 |
| Z-1492-2025 | Class II | Terumo CDI OneView Monitoring System Hematocrit... | Mar 3, 2025 |
| Z-1401-2024 | Class II | Cardiovascular Procedure Kits that include High... | Feb 20, 2024 |
| Z-1346-2023 | Class II | CAPIOX NX19 Hollow Fiber Oxygenator, Catalog Nu... | Mar 1, 2023 |
| Z-1347-2023 | Class II | CAPIOX FX25 Hollow Fiber Oxygenator, Catalog Nu... | Mar 1, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.